TY - JOUR
T1 - Prognostic Value of Hemorrhagic Brainstem Injury on Early Computed Tomography
T2 - A TRACK-TBI Study
AU - and The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Investigators
AU - Williams, John R.
AU - Nieblas-Bedolla, Edwin
AU - Feroze, Abdullah
AU - Young, Christopher
AU - Temkin, Nancy R.
AU - Giacino, Joseph T.
AU - Okonkwo, David O.
AU - Manley, Geoffrey T.
AU - Barber, Jason
AU - Durfy, Sharon
AU - Markowitz, Amy J.
AU - Yuh, Esther L.
AU - Mukherjee, Pratik
AU - Mac Donald, Christine L.
AU - Adeoye, Opeolu
AU - Badjatia, Neeraj
AU - Boase, Kim
AU - Bodien, Yelena
AU - Bullock, M. Ross
AU - Chesnut, Randall
AU - Corrigan, John D.
AU - Crawford, Karen
AU - Diaz-Arrastia, Ramon
AU - Dikmen, Sureyya
AU - Duhaime, Ann Christine
AU - Ellenbogen, Richard
AU - Feeser, V. Ramana
AU - Ferguson, Adam R.
AU - Foreman, Brandon
AU - Gardner, Raquel
AU - Gaudette, Etienne
AU - Goldman, Dana
AU - Gonzalez, Luis
AU - Gopinath, Shankar
AU - Gullapalli, Rao
AU - Hemphill, J. Claude
AU - Hotz, Gillian
AU - Jain, Sonia
AU - Keene, C. Dirk
AU - Korley, Frederick K.
AU - Kramer, Joel
AU - Kreitzer, Natalie
AU - Levin, Harvey
AU - Lindsell, Chris
AU - Machamer, Joan
AU - Madden, Christopher
AU - Martin, Alastair
AU - McAllister, Thomas
AU - McCrea, Michael
AU - Valadka, Alex
N1 - Funding Information:
We would like to thank the patients and their families for their participation and support of the TRACK-TBI study. Funding for the original TRACK-TBI study was awarded to GTM by the National Institutes of Health.
Funding Information:
Funding was provided by National Institute of Neurological Disorders and Stroke (Grant No. U01NS086090) and U.S. Department of Defense (Grant No. W81XWH-14-2-0176).
Funding Information:
Dr. Williams reports Grants from Neurosurgery Research and Education Foundation Fellowship, Grants from Adler Giersch Law Firm Endowed Fund for Traumatic Brain Injury Research, outside the submitted work. Mr. Nieblas-Bedolla has nothing to disclose. Dr. Feroze has nothing to disclose. Dr. Young has nothing to disclose. Dr. Temkin reports Grants from US Federal Government, during the conduct of the study. Dr. Giacino reports other funding from University of California at San Francisco, during the conduct of the study. Dr. Okonkwo has nothing to disclose. Dr. Manley reports Grants from United States Department of Defense, and a contract from United States Department of Defense/MTEC, Grants from NIH-NINDS, other from United States Department of Energy, other from One Mind, and other from NeuroTruama Sciences LLC, during the conduct of the study; other from National Football League Scientific Advisory Board, outside the submitted work. Mr. Barber has nothing to disclose. Dr. Durfy has nothing to disclose. Ms. Markowitz reports Grants and contracts from US Department of Defense/MTEC, and salary support from United States Department of Energy and One Mind during the conduct of the study. Dr. Yuh reports Grant support through NIH, DoD during the conduct of the study. Dr. Mukherjee reports Grants from NIH, DoD, outside the submitted work; In addition, Dr. Mukherjee has a patent US PTO Serial No. 15/782,005 pending to University of California Regents, and a patent PCT/US No. 20/42811 pending to University of California Regents. Dr. Mac Donald reports Grants from National Institute of Neurological Disorders, Grants from Department of Defense, outside the submitted work.
Publisher Copyright:
© 2021, Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
PY - 2021/10
Y1 - 2021/10
N2 - Background: Traumatic brainstem injury has yet to be incorporated into widely used imaging classification systems for traumatic brain injury (TBI), and questions remain regarding prognostic implications for this TBI subgroup. To address this, retrospective data on patients from the multicenter prospective Transforming Research and Clinical Knowledge in TBI study were studied. Methods: Patients with brainstem and cerebrum injury (BSI+) were matched by age, sex, and admission Glasgow Coma Scale (GCS) score to patients with cerebrum injuries only. All patients had an interpretable head computed tomography (CT) scan from the first 48 hours after injury and a 6-month Glasgow Outcome Scale Extended (GOSE) score. CT scans were reviewed for brainstem lesions and, when present, characterized by location, size, and type (traumatic axonal injury, contusion, or Duret hemorrhage). Clinical, demographic, and outcome data were then compared between the two groups. Results: Mann–Whitney U-tests showed no significant difference in 6-month GOSE scores in patients with BSI+ (mean 2.7) compared with patients with similar but only cerebrum injuries (mean 3.9), although there is a trend (p = 0.10). However, subclassification by brainstem lesion type, traumatic axonal injury (mean 4.0) versus Duret hemorrhage or contusion (mean 1.4), did identify a proportion of BSI+ with significantly less favorable outcome (p = 0.002). The incorporation of brainstem lesion type (traumatic axonal injury vs. contusion/Duret), along with GCS into a multivariate logistic regression model of favorable outcome (GOSE score 4–8) did show a significant contribution to the prognostication of this brainstem injury subgroup (odds ratio 0.08, 95% confidence interval 0.00–0.67, p = 0.01). Conclusions: These findings suggest two groups of patients with brainstem injuries may exist with divergent recovery potential after TBI. These data support the notion that newer CT imaging classification systems may augment traditional clinical measures, such as GCS in identifying those patients with TBI and brainstem injuries that stand a higher chance of favorable outcome.
AB - Background: Traumatic brainstem injury has yet to be incorporated into widely used imaging classification systems for traumatic brain injury (TBI), and questions remain regarding prognostic implications for this TBI subgroup. To address this, retrospective data on patients from the multicenter prospective Transforming Research and Clinical Knowledge in TBI study were studied. Methods: Patients with brainstem and cerebrum injury (BSI+) were matched by age, sex, and admission Glasgow Coma Scale (GCS) score to patients with cerebrum injuries only. All patients had an interpretable head computed tomography (CT) scan from the first 48 hours after injury and a 6-month Glasgow Outcome Scale Extended (GOSE) score. CT scans were reviewed for brainstem lesions and, when present, characterized by location, size, and type (traumatic axonal injury, contusion, or Duret hemorrhage). Clinical, demographic, and outcome data were then compared between the two groups. Results: Mann–Whitney U-tests showed no significant difference in 6-month GOSE scores in patients with BSI+ (mean 2.7) compared with patients with similar but only cerebrum injuries (mean 3.9), although there is a trend (p = 0.10). However, subclassification by brainstem lesion type, traumatic axonal injury (mean 4.0) versus Duret hemorrhage or contusion (mean 1.4), did identify a proportion of BSI+ with significantly less favorable outcome (p = 0.002). The incorporation of brainstem lesion type (traumatic axonal injury vs. contusion/Duret), along with GCS into a multivariate logistic regression model of favorable outcome (GOSE score 4–8) did show a significant contribution to the prognostication of this brainstem injury subgroup (odds ratio 0.08, 95% confidence interval 0.00–0.67, p = 0.01). Conclusions: These findings suggest two groups of patients with brainstem injuries may exist with divergent recovery potential after TBI. These data support the notion that newer CT imaging classification systems may augment traditional clinical measures, such as GCS in identifying those patients with TBI and brainstem injuries that stand a higher chance of favorable outcome.
KW - Brainstem injury
KW - Computed tomography
KW - Outcomes
KW - Traumatic axonal injury
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=85114036053&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114036053&partnerID=8YFLogxK
U2 - 10.1007/s12028-021-01263-8
DO - 10.1007/s12028-021-01263-8
M3 - Article
C2 - 34309784
AN - SCOPUS:85114036053
SN - 1541-6933
VL - 35
SP - 335
EP - 346
JO - Neurocritical Care
JF - Neurocritical Care
IS - 2
ER -